Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

2 Therapeutics

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
E2511		Alzheimer's Disease (Phase 1)	Eisai Co., Ltd.	Cholinergic System	Small Molecule
SUVN-G3031	Samelisant, 17v	Alzheimer's Disease (Phase 1)	Suven Life Sciences Ltd	Cholinergic System, Other Neurotransmitters	Small Molecule